haku: @indexterm bio-technology / yhteensä: 177
viitteet: 18-27 / 177
« edellinen sivu | seuraava sivu »
 otsikkovuositekijä
18.
The role of pest resistance in biotechnology R&D investment strategy
Journal of Environmental Economics and Management
2008 : MAR, VOL. 55:2, p. 213-228
 2008 O'Shea, L.
Ulph, A.
19.
Managing the risks associated with using biomedical ethics advice
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p. 99-109
 2008 Eaton, M. L.
20.
Marketing in Heterozygous advantage
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p. 85-97
 2008 Jones, G. T.
Hagtwedt, R.
21.
Canada's stem cell corporation: Aggregate concerns and the question of public trust
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p.73-84
 2008 Herder, M.
Brian, J. D.
22.
Sowing the seeds of reason in the field of the terminator debate
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p.65-72
 2008 Bustos, K.
23.
Social exclusion and transgenic technology: The case of Brazilian agriculture
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p. 45-63
 2008 Hall, J.
Matos, S.
Langford, C. L.
24.
Challenges for corporate ethics in marketing genetic tests
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p. 33-44
 2008 Williams-Jones, B.
Ozdemir, V.
25.
The ethical challenges of direct-to-consumer genetic testing
Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p.17-31
 2008 Berg, C.
Fryer-Edwards, K.
26.
Technology, cooperation and stock market value: an event study of new partnership announcements in the biotechnology and pharmaceutical industries
Economics of innovation and new technology
2007 : JAN-MAR, VOL. 16:1-2, p. 31-49
 2007 Campart, S.
Pfister, E.
27.
Branching out
Business Strategy Review
2007 : VOL. 18:2, p. 19-23
 2007 Peters, G.
« edellinen sivu | seuraava sivu »
SCIMA